-
Product Insights
Ferlach-Maria Rain
Ferlach-Maria Rain is a Hydro project located in Carinthia, Austria. The project is owned by VERBUND Hydro Power GmbH. The project came online in 1975. Empower your strategies with our Ferlach-Maria Rain report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Rain Cements APSPDCL Solar PV Park
Rain Cements APSPDCL Solar PV Park is a solar PV project located in Andhra Pradesh, India. The project is owned by Greenko Energies Pvt Ltd and was developed by Greenko Energies Pvt Ltd; SunEdison Energy India Pvt Ltd. The project came online in 2017. Empower your strategies with our Rain Cements APSPDCL Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Company Insights
Innovation and Patenting activity of Rain Industries Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Rain Industries Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sitravatinib Malate in Squamous Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sitravatinib Malate in Squamous Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sitravatinib Malate in Squamous Non-Small Cell Lung Cancer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Epcoritamab in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Epcoritamab in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epcoritamab in Marginal Zone B-cell Lymphoma Drug Details: Epcoritamab-Bysp...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Niraparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Niraparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Niraparib in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:...
-
Sector Analysis
United Kingdom (UK) Accessories Market Analysis, Trends, Consumer Preferences and Forecast to 2027
United Kingdom (UK) Accessories Market Report Overview The United Kingdom (UK) accessories market size was £5.9 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2027. Even though inflationary pressures led consumers to cut back on fashion spend due to higher prices and less discretionary income, the high presence of luxury goods within the fashion sector allowed accessories to achieve slightly stronger growth than clothing and footwear. UK Accessories Market Outlook, 2023-2027...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IC9 CAR.19 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IC9 CAR.19 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IC9 CAR.19 in B-Cell Acute...
-
Product Insights
Squamous Non-Small Cell Lung Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Drugs In Development, 2023’, provides an overview of the Squamous Non-Small Cell Lung Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Squamous Non-Small Cell Lung Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-6358 in Lung Adenocarcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-6358 in Lung Adenocarcinoma Drug Details: JNJ-6358 is under development for the treatment of solid...